Bhavya Yarlagadda

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 28, 2019
Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma.

Bhavya Yarlagadda, Vaishnavi Kamatham, Ashton Ritter

Pageof 1

Frequent Collaborators